PerkinElmer AI Price Prediction

With an EPS of 4.55 and a PE ratio of 27.18, PerkinElmer is priced at a moderate growth multiple relative to its earnings. The valuation suggests investors expect steady, but not hyper-aggressive, earnings growth. In the absence of detailed revenue and margin history, the earnings profile looks solid but not clearly mispriced in either direction.

• EPS of 4.55 indicates the company is consistently profitable and generating meaningful earnings per share.
• A PE ratio of 27.18 places the stock in a growth-leaning valuation range, implying the market is pricing in continued earnings expansion rather than deep value.
• Without explicit revenue and margin trend data, profitability appears adequate but not clearly under- or over-valued based solely on the PE/EPS combination.

At $123.58, PerkinElmer is trading above its 200-day moving average of $110.50, indicating a positive intermediate-term trend. However, without RSI data, it’s difficult to judge overbought or oversold conditions, and the premium to the 200-day average is notable but not extreme. Overall, price action leans constructive but not decisively bullish from a technical standpoint.

• Current price of $123.58 is meaningfully above the 200-day moving average of $110.50, signaling an established uptrend and positive long-term momentum.
• The distance above the 200-day moving average suggests improving sentiment but not necessarily a parabolic move that would clearly indicate a near-term top.
• Lack of RSI data limits visibility into short-term overbought/oversold conditions, so the technical picture is positive but not strong enough alone to justify a clear bullish call.

PerkinElmer’s social media footprint is sizable on LinkedIn and stable to slightly positive across other platforms, but growth rates are very modest. The data suggest a mature, B2B-focused brand with steady engagement rather than a rapidly accelerating commercial story. These signals neither strongly support nor contradict a bullish equity thesis.

• LinkedIn presence is strong at 226,799 followers, consistent with a well-established life sciences/industrial brand focused on professional audiences.
• Follower changes across Twitter/X (9,201, flat), Instagram (5,214, +0.2%), Facebook (25,041, -0.1%), and YouTube (15,700, +0.6%) show very small moves, indicating stable but not rapidly expanding digital engagement.
• The slow, mixed follower trends suggest a mature company with steady visibility rather than one experiencing a surge in brand interest that might foreshadow outsized near-term growth.

PerkinElmer’s valuation, earnings profile, and technical setup collectively point to a neutral outlook. The stock trades at a reasonable growth multiple, sits above its 200-day moving average, and shows stable but unspectacular alternative data trends. There are signs of steady strength, but not enough evidence from the provided data to justify a distinctly bullish or bearish stance.

• Earnings and valuation (EPS 4.55, PE 27.18) support a view of a healthy, moderately growth-priced business rather than a clear bargain or an obviously overvalued name.
• Price trading above the 200-day moving average with modest alternative data momentum suggests a stable, established company with incremental, not explosive, growth expectations.